Follow
Jonas H Fagerberg
Jonas H Fagerberg
Principal Scientist, Disruptive Pharma
Verified email at disruptivepharma.com
Title
Cited by
Cited by
Year
Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media
JH Fagerberg, O Tsinman, N Sun, K Tsinman, A Avdeef, CAS Bergstrom
Molecular pharmaceutics 7 (5), 1419-1430, 2010
1982010
Is the full potential of the biopharmaceutics classification system reached?
CAS Bergström, SBE Andersson, JH Fagerberg, G Ragnarsson, A Lindahl
European Journal of Pharmaceutical Sciences 57, 224-231, 2014
952014
Ethanol effects on apparent solubility of poorly soluble drugs in simulated intestinal fluid
JH Fagerberg, Y Al-Tikriti, G Ragnarsson, CAS Bergstrom
Molecular pharmaceutics 9 (7), 1942-1952, 2012
732012
Computational prediction of drug solubility in fasted simulated and aspirated human intestinal fluid
JH Fagerberg, E Karlsson, J Ulander, G Hanisch, CAS Bergström
Pharmaceutical research 32, 578-589, 2015
712015
Optimizing solubility and permeability of a biopharmaceutics classification system (BCS) class 4 antibiotic drug using lipophilic fragments disturbing the crystal lattice
U Tehler, JH Fagerberg, R Svensson, M Larhed, P Artursson, ...
Journal of medicinal chemistry 56 (6), 2690-2694, 2013
682013
Intestinal solubility and absorption of poorly water soluble compounds: predictions, challenges and solutions
JH Fagerberg, CAS Bergström
Therapeutic delivery 6 (8), 935-959, 2015
54*2015
Concomitant intake of alcohol may increase the absorption of poorly soluble drugs
JH Fagerberg, E Sjögren, CAS Bergström
European Journal of Pharmaceutical Sciences 67, 12-20, 2015
472015
Formulation of the Microbicide INP0341 for In Vivo Protection against a Vaginal Challenge by Chlamydia trachomatis
C Pedersen, A Slepenkin, SBE Andersson, JH Fagerberg, CAS Bergström, ...
PLoS One 9 (10), e110918, 2014
142014
Physiologically based biopharmaceutics modeling of regional and colon absorption in humans
C Tannergren, H Jadhav, E Eckernäs, J Fagerberg, P Augustijns, ...
European Journal of Pharmaceutics and Biopharmaceutics 186, 144-159, 2023
52023
Affinity of lipophilic drugs to mixed lipid aggregates in simulated gastrointestinal fluids
JH Fagerberg, P Zarmpi, H Jabbar, N Fotaki
Journal of Pharmaceutical Sciences 110 (1), 186-197, 2021
32021
Experimental and computational predictions of drug solubility in human gastrointestinal fluids
JH Fagerberg
Acta Universitatis Upsaliensis, 2014
22014
The system can't perform the operation now. Try again later.
Articles 1–11